4
Changes in Ownership
Kiniksa Pharmaceuticals International, plc Filed Acc 0001415889-25-015780
CHIEF COMMERCIAL OFFICER sold 27,594 shares at $29.02 ($800,778)
- CHIEF COMMERCIAL OFFICER acquired 27,594 shares (option exercise)
- Traded under a Rule 10b5-1 plan
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Moat Ross CHIEF COMMERCIAL OFFICER | 2025-06-03 | Option exercise 10b5-1 | +27,594 | $13.35 | $368,380 | 37,009 | D |
| Moat Ross CHIEF COMMERCIAL OFFICER | 2025-06-03 | Sale 10b5-1 | −27,594 | $29.02 | $800,778 | 9,415 | D |
| Derivatives | |||||||
| Moat Ross CHIEF COMMERCIAL OFFICER | 2025-06-03 | Option exercise · Share Option 10b5-1 | −27,594 | 0 | D | ||
| Open-market sales · 27,594 sh · avg $29.02 · $800,778 | |||||||
Loading xslF345X05/form4-06052025_080613.xml…